These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 14624191)
1. GABA and schizophrenia: a review of basic science and clinical studies. Wassef A; Baker J; Kochan LD J Clin Psychopharmacol; 2003 Dec; 23(6):601-40. PubMed ID: 14624191 [TBL] [Abstract][Full Text] [Related]
2. The rise of a new GABA pharmacology. Möhler H Neuropharmacology; 2011 Jun; 60(7-8):1042-9. PubMed ID: 21035473 [TBL] [Abstract][Full Text] [Related]
3. A rodent model of schizophrenia derived from postmortem studies. Berretta S; Gisabella B; Benes FM Behav Brain Res; 2009 Dec; 204(2):363-8. PubMed ID: 19539659 [TBL] [Abstract][Full Text] [Related]
4. The role of cortical inhibition in the pathophysiology and treatment of schizophrenia. Daskalakis ZJ; Fitzgerald PB; Christensen BK Brain Res Rev; 2007 Dec; 56(2):427-42. PubMed ID: 17980435 [TBL] [Abstract][Full Text] [Related]
5. The role of GABA in anxiety disorders. Lydiard RB J Clin Psychiatry; 2003; 64 Suppl 3():21-7. PubMed ID: 12662130 [TBL] [Abstract][Full Text] [Related]
7. The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia. Liu SK; Fitzgerald PB; Daigle M; Chen R; Daskalakis ZJ Biol Psychiatry; 2009 Mar; 65(6):503-9. PubMed ID: 18950746 [TBL] [Abstract][Full Text] [Related]
8. [Dopaminergic receptor activity and the evolution of schizophrenia]. Fodoreanu L Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(2):131-4. PubMed ID: 2864729 [No Abstract] [Full Text] [Related]
9. The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline. Vinkers CH; Mirza NR; Olivier B; Kahn RS Expert Opin Investig Drugs; 2010 Oct; 19(10):1217-33. PubMed ID: 20812877 [TBL] [Abstract][Full Text] [Related]
10. [On the role of GABA in anxiety and depression]. Kaluev AV; Nutt DJ Eksp Klin Farmakol; 2004; 67(4):71-6. PubMed ID: 15500054 [TBL] [Abstract][Full Text] [Related]
11. The neuronal pathology of schizophrenia: molecules and mechanisms. Reynolds GP; Harte MK Biochem Soc Trans; 2007 Apr; 35(Pt 2):433-6. PubMed ID: 17371293 [TBL] [Abstract][Full Text] [Related]
12. GABA, gamma-hydroxybutyric acid, and neurological disease. Wong CG; Bottiglieri T; Snead OC Ann Neurol; 2003; 54 Suppl 6():S3-12. PubMed ID: 12891648 [TBL] [Abstract][Full Text] [Related]
13. How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia? Kondziella D; Brenner E; Eyjolfsson EM; Sonnewald U Neurochem Int; 2007 Jan; 50(2):291-301. PubMed ID: 17084946 [TBL] [Abstract][Full Text] [Related]
14. Basic developmental rules and their implications for epilepsy in the immature brain. Ben-Ari Y Epileptic Disord; 2006 Jun; 8(2):91-102. PubMed ID: 16793570 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiologically based treatment interventions in schizophrenia. Lewis DA; Gonzalez-Burgos G Nat Med; 2006 Sep; 12(9):1016-22. PubMed ID: 16960576 [TBL] [Abstract][Full Text] [Related]
16. Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia. Bencherif M; Stachowiak MK; Kucinski AJ; Lippiello PM Med Hypotheses; 2012 May; 78(5):594-600. PubMed ID: 22336089 [TBL] [Abstract][Full Text] [Related]
17. The biological basis of schizophrenia: new directions. Weinberger DR J Clin Psychiatry; 1997; 58 Suppl 10():22-7. PubMed ID: 9265913 [TBL] [Abstract][Full Text] [Related]
18. Role of GABA in memory and anxiety. Kalueff A; Nutt DJ Depress Anxiety; 1996-1997; 4(3):100-10. PubMed ID: 9166638 [TBL] [Abstract][Full Text] [Related]